Delivery Order SPE2DB20D3101-SPE2DB25FRPX0
Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for delivery of the pharmaceutical product Mounjaro (7.5 mg/0.5 mL pen) to the Defense Logistics Agency (DLA). The $36,978.47 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024, with a completion date of October 25, 2024. The contract is a delivery order, not associated with a set-aside designation, and is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a ceiling value of $3,748.35 and a performance period ending on July 1, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This is a delivery order contract with a firm-fixed-price pricing type. The contract does not have a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $1,632.54 and has an ultimate completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen, 0.5 ml, with a total ceiling value of $57,922.88. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of December 31, 2024. It is not designated as a...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The award, valued at $1,052.00, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 14, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,260, is a delivery order for the medication Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside...
- This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,189.22, is for the delivery of the drug Mounjaro 7.5 mg/0.5 mL pen 0.5 mL. The contract has an ultimate completion date of April 7, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. The contract has a ceiling value of $23,215.87 and an ultimate completion date of December 6, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a firm fixed-price arrangement and was awarded without any set-aside designations, indicating open...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,946.01. The contract is a firm-fixed-price, non-set-aside arrangement with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...